Genmab A/S GENMAB ORD SHS/ DK0010272202 /
04/10/2024 16:59:49 | Var. -7.00 | Volume | Denaro04/10/2024 | Lettera04/10/2024 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
1,587.50DKK | -0.44% | 2,353 Fatturato: 3.71 mill. |
-Quantità in denaro: - | -Quantità in lettera: - | 104.89 bill.DKK | - | 23.82 |
Newsfile Corp
18:05
ROSEN, A LEADING LAW FIRM, Encourages Visa Inc. Investors to Inquire About Securities Class Action I...
Newsfile Corp
17:32
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Impo...
Newsfile Corp
17:08
LULU Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds lululemon athletica inc. (LULU) ...
Newsfile Corp
17:08
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Endava plc Investors to Secure Counsel Before Important ...
Newsfile Corp
16:58
DesignRush Shortlists the Most Competitive Web Development Companies in October 2024
Newsfile Corp
16:03
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Bumble Inc. Investors to Secure Counsel Before Imp...
Newsfile Corp
15:55
NNE DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages NANO Nuclear Energy, Inc. Investors ...
Newsfile Corp
15:52
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Impo...